Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.

A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.

News stories about clinical trials testing potential treatments were among the top 10 most-read articles on ALS News Today in ...

The binding term sheet is subject to finalization of a definitive agreement, anticipated in the first quarter of 2025 ... targets multiple ALS disease pathways such as motor neuron degeneration ...

Former Minnesota Twins first baseman Carlos Santana has signed a one-year deal to join the Cleveland Guardians in 2025, according to multiple reports. ESPN's Jeff Passan says the deal is worth $12 ...

A drug being developed by scientists in Japan to treat Alzheimer's is also effective against the neurodegenerative ALS disease ... brain and spinal cord to be first of its kind, Kyodo News ...

18, 2024 (HealthDay News) -- In a case first reported in Louisiana last Friday, a patient has now developed the first known case of bird flu so severe as to require hospitalization, according to the U ...

therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Ryoncil is the first FDA-approved MSC therapy.

On Tuesday, the ALS Society of Alberta and Alberta Neuroscience announced the first-ever recipients of ... find solutions for those impacted by the disease. “Ann’s strength and hope inspired ...

Early signs of breast cancer may include a lump or ... or thickened skin around the nipple or areola may be a sign of Paget’s disease of the nipple. This is a rare type of breast cancer, but ...

21, 2024 — New research has revealed a connection between ancient viral DNA embedded in the human genome and the genetic risk for two major diseases ... picture of the early signs of multiple ...